Laser ablation–inductively coupled plasma–mass spectrometry imaging in biology

PA Doble, RG de Vega, DP Bishop, DJ Hare… - Chemical …, 2021 - ACS Publications
Elemental imaging gives insight into the fundamental chemical makeup of living organisms.
Every cell on Earth is comprised of a complex and dynamic mixture of the chemical elements …

Therapeutics in the pipeline targeting α-synuclein for Parkinson's disease

HG Jasutkar, SE Oh, MM Mouradian, E Barker - Pharmacological reviews, 2022 - Elsevier
Parkinson's disease (PD) is the second most common neurodegenerative disorder and the
fastest growing neurologic disease in the world, yet no disease-modifying therapy is …

Pathogenic impact of α-synuclein phosphorylation and its kinases in α-synucleinopathies

I Kawahata, DI Finkelstein, K Fukunaga - International journal of …, 2022 - mdpi.com
α-Synuclein is a protein with a molecular weight of 14.5 kDa and consists of 140 amino
acids encoded by the SNCA gene. Missense mutations and gene duplications in the SNCA …

[HTML][HTML] Parkinson's disease: alterations in iron and redox biology as a key to unlock therapeutic strategies

L Ma, MG Azad, M Dharmasivam, V Richardson… - Redox biology, 2021 - Elsevier
A plethora of studies indicate that iron metabolism is dysregulated in Parkinson's disease
(PD). The literature reveals well-documented alterations consistent with established dogma …

Iron brain menace: the involvement of ferroptosis in Parkinson disease

KJ Lin, SD Chen, KL Lin, CW Liou, MY Lan… - Cells, 2022 - mdpi.com
Parkinson disease (PD) is the second-most common neurodegenerative disease. The
characteristic pathology of progressive dopaminergic neuronal loss in people with PD is …

Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective

PJ Derry, ML Hegde, GR Jackson, R Kayed… - Progress in …, 2020 - Elsevier
The complexity of Alzheimer's disease (AD) complicates the search for effective treatments.
While the key roles of pathologically modified proteins has occupied a central role in …

[HTML][HTML] ALOX5 inhibition protects against dopaminergic neurons undergoing ferroptosis

K Li, M Wang, ZH Huang, M Wang, WY Sun… - Pharmacological …, 2023 - Elsevier
Oxidative disruption of dopaminergic neurons is regarded as a crucial pathogenesis in
Parkinson's disease (PD), eventually causing neurodegenerative progression.(-) …

Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis

D Devos, ZI Cabantchik, C Moreau, V Danel… - Journal of Neural …, 2020 - Springer
Focal iron accumulation associated with brain iron dyshomeostasis is a pathological
hallmark of various neurodegenerative diseases (NDD). The application of iron-sensitive …

Targeting α-synuclein in Parkinson's disease: progress towards the development of disease-modifying therapeutics

D Savitt, J Jankovic - Drugs, 2019 - Springer
Abstract Parkinson's disease (PD), the second most common neurodegenerative movement
disorder, is characterized by progressive motor and non-motor symptoms [1]. Despite …

Untangling tau and iron: exploring the interaction between iron and tau in neurodegeneration

SS Rao, PA Adlard - Frontiers in Molecular Neuroscience, 2018 - frontiersin.org
There is an emerging link between the accumulation of iron in the brain and abnormal tau
pathology in a number of neurodegenerative disorders, such as Alzheimer's disease (AD) …